Mission Boost Grants (MBG)

Funding Agency:
American Cancer Society

Mission Boost Grants (MBG) are designed to support select current and past ACS grantees specifically for the translation of their research to human testing. MBGs are opportunities for American Cancer Society (ACS) grantees to seek additional, or “boost,” resources for innovative, high-risk/high-reward projects.

MBGs offer 2 stages of funding:

  • Stage I requires the investigator to develop outcome-specific, unequivocal milestones that reduce the risks of studying a new drug, device, or procedure in patients.  
  • Stage II supports testing in cancer patients.

Deadlines: April 1*  and Oct. 15* 

Agency Website

Eligibility Requirements

Stage I Mission Boost

You ARE eligible to submit a proposal if you:

  • Work at a US academic institution or eligible non-profit 
  • Have an independent, full-time faculty appointment
  • Have held or currently hold one of these ACS grants (or previous versions of such awards) for a minimum of 1 year:
    • Research Scholar Grant (RSG)
    • Clinician Scientist Development Grant (CSDG)
    • Mentored Research Scholar Grant (MRSG)
    • Cancer Control Career Development Award (CCCDA) 
    • Pilot and Exploratory Projects in Palliative Care (PEP) Award
    • ACS Postdoctoral Fellowship (previous fellows only)

Stage II Mission Boost

You ARE eligible to submit a proposal if you:

  • Work at a US academic institution or eligible non-profit 
  • Have an independent, full-time faculty appointment
  • Previously held or currently hold a Stage I Mission Boost Grant for a minimum of 18 months AND have completed Stage I milestones

Amount Description

Stage I Mission Boost 

Applicants may propose up to 2 years with up to $100,000 a year for direct costs, plus 20% indirect costs. 

Stage II Mission Boost

Applicants may propose up to 18 months and $500,000 for direct costs, plus 20% indirect costs.

Funding Type

Grant

Eligibility

Faculty

Category

Medical
Medical - Clinical Science
Medical - Translational

External Deadline

April 1, 2024